Inventor · Silver Spring, MD, US

Amir Tamiz

17Patents
4h-index
23Co-inventors
60Inventor score

Filing activity: Oct 7, 1999 → Aug 10, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US6586405B2 Non-covalent inhibitors of urokinase and blood vessel formation Human Necessities 19 Expired
US8785374B2 Inhibitors of mammalian tight junction opening Chemistry; Metallurgy 7 Active
US8957032B2 Inhibition of gliadin peptides Human Necessities 6 Active
US8299017B2 Use of tight junction antagonists to treat inflammatory bowl disease Chemistry; Metallurgy 6 Active
US8796203B2 Use of tight junction antagonists to treat inflammatory bowel disease Chemistry; Metallurgy 4 Active
US7019019B2 Matriptase inhibitors and methods of use Chemistry; Metallurgy 4 Expired
US8198233B2 Synthetic peptides that enhance tight junction permeability Human Necessities 4 Active
US6440996B1 Monomeric and dimeric heterocycles, and therapeutic uses thereof Chemistry; Metallurgy 3 Expired
US8557763B2 Synthetic peptides that enhance tight junction permeability Human Necessities 3 Active
US10526372B2 Inhibition of gliadin peptides Human Necessities 2 Active
US6605621B1 Monomeric and dimeric heterocycles, and therapeutic uses thereof Chemistry; Metallurgy 1 Expired
US10106597B2 Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases Chemistry; Metallurgy 1 Active
US9056923B2 Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases Chemistry; Metallurgy 1 Active
US11149063B2 Peptide inhibitors of tight junction permeability Human Necessities 1 Active
US11155603B2 Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases Chemistry; Metallurgy 0 Active
US7262211B2 Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation Human Necessities 0 Expired
US10774131B2 Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.